Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A. van der Veer, V.H.J. van der Velden, M.E. Willemse, P.G. Hoogeveen, E.F. Petricoin, H.B. Beverloo, G. Escherich, M.A. Horstmann, F. Pieters, M.L. van den Boer

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

7 Citations (Scopus)
Original languageEnglish
Article numbere181
JournalBlood Cancer Journal
DOIs
Publication statusPublished - 2014

Cite this

van der Veer, A., van der Velden, V. H. J., Willemse, M. E., Hoogeveen, P. G., Petricoin, E. F., Beverloo, H. B., Escherich, G., Horstmann, M. A., Pieters, F., & van den Boer, M. L. (2014). Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood Cancer Journal, [e181]. https://doi.org/10.1038/bcj.2014.5